Pharmarov Consulting Limited - Accounts to registrar (filleted) - small 22.3

REGISTERED NUMBER: 06663823 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 July 2022

for

Pharmarov Consulting Limited

Page

Company Information

1

Statement of Financial Position

2

Notes to the Financial Statements

4

DIRECTORS:

Dr Ketan Lalit Vora

Mrs Anita Ketan Vora

SECRETARY:

Dr Ketan Lalit Vora

REGISTERED OFFICE:

Devonshire House

582 Honeypot Lane

Stanmore

MIDDLESEX

HA7 1JS

REGISTERED NUMBER:

06663823 (England and Wales)

FIXED ASSETS

Intangible assets

4

4,500

-

Tangible assets

5

945

1,072

5,445

1,072

CURRENT ASSETS

Debtors

6

27,083

8,520

Cash at bank

112,213

305,136

139,296

313,656

CREDITORS

Amounts falling due within one year

7

109,802

168,718

NET CURRENT ASSETS

29,494

144,938

TOTAL ASSETS LESS CURRENT LIABILITIES

34,939

146,010

PROVISIONS FOR LIABILITIES

1,035

204

NET ASSETS

33,904

145,806

CAPITAL AND RESERVES

Called up share capital

100

100

Retained earnings

33,804

145,706

SHAREHOLDERS' FUNDS

33,904

145,806

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2022 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 8 November 2022 and were signed on its behalf by:

Dr Ketan Lalit Vora - Director

1.	STATUTORY INFORMATION

Pharmarov Consulting Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Computer software is being amortised evenly over its estimated useful life of nil years.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

25% on cost

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2021 - 3 ) .

4.	INTANGIBLE FIXED ASSETS

Other

intangible

assets

£

COST

Additions

6,000

At 31 July 2022

6,000

AMORTISATION

Charge for year

1,500

At 31 July 2022

1,500

NET BOOK VALUE

At 31 July 2022

4,500

5.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 August 2021

6,690

Additions

441

At 31 July 2022

7,131

DEPRECIATION

At 1 August 2021

5,618

Charge for year

568

At 31 July 2022

6,186

NET BOOK VALUE

At 31 July 2022

945

At 31 July 2021

1,072

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.7.22

31.7.21

£

£

Trade debtors

27,083

8,520

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.7.22

31.7.21

£

£

Trade creditors

3,672

2,100

Taxation and social security

6,707

60,144

Other creditors

99,423

106,474

109,802

168,718

8.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES